Synergistic Antibacterial and Antibiofilm Activity of the MreB Inhibitor A22 Hydrochloride in Combination with Conventional Antibiotics against Pseudomonas aeruginosa and Escherichia coli Clinical Isolates

In the era of antibiotic resistance, the bacterial cytoskeletal protein MreB is presented as a potential target for the development of novel antimicrobials. Combined treatments of clinical antibiotics with anti-MreB compounds may be promising candidates in combating the resistance crisis, but also i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotzialampou, Anastasia, Protonotariou, Efthymia, Skoura, Lemonia, Sivropoulou, Afroditi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413048/
https://www.ncbi.nlm.nih.gov/pubmed/34484344
http://dx.doi.org/10.1155/2021/3057754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413048/
https://www.ncbi.nlm.nih.gov/pubmed/34484344
http://dx.doi.org/10.1155/2021/3057754

Ejemplares similares